Concepedia

Publication | Closed Access

Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial

102

Citations

0

References

2013

Year

JA Ledermann, Timothy Perren, FA Raja, Andrew Embleton-Thirsk, G.J.S. Rustin, Gordon C. Jayson, S.B. Kaye, AM Swart, Michelle Vaughan, Hal W. Hirte
UCL Discovery (University College London)

No additional data available for this publication yet. Check back later!